CV | Moradi MD

Education

2017 – Master of Business Administration (MBA), Wharton University of Pennsylvania School of Business
1995–1999 – Head & Neck Surgery Residency, Duke University Medical Center
1994 – Doctor of Medicine, University of California San Diego Medical School; Honors
1989 – Bachelor of Science: Biological Sciences, University of California, San Diego; Summa Cum Laude

Medical Licensure

California State Medical License
North Carolina State Medical License
Nevada State Medical License

Certification

Board Certified, American Board of Facial Plastic & Reconstructive Surgery
Board Certified, American Academy of Otolaryngology Head & Neck Surgery
Good Clinical Practices

Professional Experience

Pacific Clinical Innovations Inc. (2024–Present)

CEO, Principal Investigator

Moradi MD (2000–Present)

CEO, Medical Director

Professional Memberships

American Academy of Facial Plastic & Reconstructive Surgery
California Medical Society
Association of Clinical Research Professionals
American Society of Laser Medicine & Surgery
California Society of Facial Plastic Surgery

Industry Experience

Board of Directors – CAP MPT
CAP-MPT Cosmetic Procedures Committee
Face to Face Committee – American Academy of Facial Plastic Surgery
Regulatory and Socioeconomic Affairs Committee – American Academy of Facial Plastic Surgery
Patient Safety Committee – American Academy of Facial Plastic Surgery

Hospital Privileges

Tri City Medical Center, Oceanside, CA (Facial Plastic Surgery)
Scripps Memorial Hospital, La Jolla, CA (Facial Plastic Surgery)

Honors and Awards

1994 – The Hamburger Award for best student independent study project: ICG-a and Angiofibroma
1991 – NIH Student Summer Research Grant
1993 – American Medical Association Educational Research Foundation Grant
1994 – Excellence in Research Award – Western Medical Research Committee

Disclosures

Allergan – Consultant, Advisory Board, Faculty, Clinical Research Investigator
Merz Aesthetics – Consultant, Advisory Board, Member of Steering Committee, Clinical Research Investigator
Galderma – Consultant, Advisory Board, Clinical Research Investigator
L'Oréal – Consultant, Clinical Research Investigator
Skin Medica – Consultant, Advisory Board, Clinical Research Investigator
BTL – Consultant, Speaker, Clinical Research Investigator
Lutronic – Consultant, Speaker, Clinical Research Investigator
Alastin – Consultant, Clinical Research Investigator
Evolus – Consultant, Clinical Research Investigator
Recros Medica – Clinical Research Investigator
GloPharma (Ourself) – Consultant, Clinical Research Investigator, Stockholder
Teoxane – Advisory Board, Consultant
Symatase – Clinical Research Investigator
Canfield – Consultant
Veramdermics – Clinical Research Investigator

Research

US HARMONY in DIVERSITY: A Prospective, Open-label Study to Evaluate Subject Satisfaction with the Overall Face and Neck Appearance After Combined Treatment. Jan 2024–Present
A randomized, double-blind, placebo-controlled, parallel group, multi-dose study to evaluate the efficacy and safety of VDPHLO1 in male subjects with Androgenetic Alopecia. Nov 2024–Present
A monocenter, double-blinded study to evaluate skin rejuvenation and anti-aging benefits of two topical periorbital eye formulations post ProFractional® Laser Resurfacing. Oct 2024–Present
A single center, split-face, placebo-controlled, double-blind randomized study of a novel topical cosmetic product after Sofwave treatment in the lower face/neck. Oct 2024–Present
A Multi-Center, Open-label Trial Evaluating a Plant Adaptogen Serum for Facial Skin Quality in Females Affected by Hormonal Decline. Sep 2024–Present
Open-label study of a topical cosmetic product following facial neurotoxin injections. Aug 2024–Jan 2024
A Double-Blinded, Randomized, Non-Inferiority Study of EvolysseT™ Lips for Lip Augmentation. Jul 2024–Present
Multicenter, evaluator-blinded study of GP0121 for lip augmentation and perioral area correction. May 2024–Present
Phase 3 study of Botox® for masseter muscle prominence. May 2024–Present
Multicenter, open-label study on Botox® Cosmetic for upper facial lines. Apr 2024–Feb 2025
Split-face study of HA+ replenishing eye serum in upper blepharoplasty patients. Apr 2024–Oct 2024
Open-label study of hydrating serum following facial injections or microneedling. Apr 2024–Nov 2024
Comparator-controlled study of GP0116 for dynamic facial wrinkles. Mar 2024–Present
Placebo-controlled lip plumping study for previously augmented patients. Jan 2024–Jul 2024
Real-world study of long-term Botox® use for upper facial lines. Dec 2023–Feb 2025
RHA®4 study for correction of sagging jawline. Oct 2023–Present
TriHex Technology® Serum pre-facelift conditioning study. Oct 2023–Oct 2024
Vitamin C antioxidant serum for facial photodamage. Mar 2023–Sep 2023
Restylane Contour for temple hollowing. Mar 2023–Jan 2025
Belotero® Intense Lidocaine for lip augmentation. Mar 2023–Jan 2025
Revalidation of Mid-Face Volume Deficit Scale. Feb 2023–May 2023
Topical hyaluronic acid facial product study. Jul 2022–Oct 2022
Precise Sculpt Dermal Filler for mid-face volume. Jul 2022–Present
Restylane Kysse for lip augmentation in Chinese subjects. Jun 2022–Dec 2023
OM1114-DP for glabellar lines. May 2022–Oct 2023
Botox® for platysmal prominence. May 2022–2023
CoolSculpting system for fat reduction. Apr 2022–Feb 2023
Cosmetic formulation for crow’s feet wrinkles. Apr–Jun 2022
AGN-151586 for glabellar lines. Mar 2022–Oct 2023
Diluted RADIESSE® for décolleté wrinkles. Dec 2021–Jan 2024
Skincare regimen and spot peel for solar lentigines. Sep–Dec 2021
Cellulite outcome measure study. Oct–Dec 2021
Décolletage outcome support study. Jun–Jul 2021
Octave System for eyebrow lifting and facial appearance. May 2021–Feb 2023
CONFIRM study for NuvellusT™ submental contouring. Apr 2021–Jul 2022
GAL1906 for décolleté wrinkles. Jan 2021–Sep 2022
Belotero Balance (+) for infraorbital hollow. Sep 2020–Sep 2022
OnabotulinumtoxinA for depressor anguli oris. Feb 2020–Jan 2021
QM1114-DP for glabellar lines (READY - 1). Jan 2020–Jul 2021
INFORM study: Rotational Fractional Resection. Nov 2019–Jul 2020
ClinRO and PRO instruments for facial lines. Jan 2019–Jan 2020
GAL1704 for cheek augmentation. Dec 2018–Jun 2020
AbobutulinumtoxinA for glabellar lines. Nov 2018–Jul 2020
Alastin TransFORM with cryolipolysis. Sep 2018–Sep 2019
Restylane® Defyne for chin augmentation. Aug 2018–Mar 2020
Radiesse (+) for jawline contour. Jul 2018–Jul 2020
Post-IPL skin care regimen study. Mar–Aug 2018
Ulthera® System for submental/neck lifting (Chinese patients). Mar–Nov 2018
Alastin with CoolSculpting. Feb–Oct 2018
Lutronic Infini + LaseMD combination treatment. Dec 2017–Jul 2018
Lutronic LaseMD pilot. Apr–Oct 2017
Radiesse hand volume loss safety study. Jun 2016–Jun 2019
Restylane® Lyft vs no treatment for hand volume. Dec 2015–Mar 2017
Radiesse® radiologic evaluation study. Nov 2015–Jul 2018
Radiofrequency device for abdominal contouring. Jul 2014–Jan 2015
Juvederm Ultra XC vs Belotero Balance for perioral lines. Oct 2013–Jul 2014
Belotero® injection adverse event comparison. Apr 2013
Radiesse for hand treatment. 2013–2014
Perlane-L for midface contour correction. 2012–2014
Perlane-L for temporal fossa volume. 2011
Restylane-L/Perlane-L for perioral wrinkles. 2011
Latisse (bimatoprost) for hypotrichosis. 2011
Chronic sinusitis and antibiotics outcome research. 1998
IGF-B on nasopharyngeal angiofibroma. 1993–1994
Taste evaluation post mastoidectomy. 1993
HIV and sinonasal disease correlation. 1992
Alzheimer’s disease progression. 1988

Schedule a Consultation

Publications

Green JB, Del Campo R, Durkin AJ, et al. Long-term duration and safety of Radiesse (+) for the treatment of jawline. J Cosmet Dermatol. 2024; 00: 1–8. doi:10.1111/jocd.16436
Moradi A, Shafiq F, Robison T, Colvan L, Poehler J, Widgerow AD. "Multicenter evaluation of a topical antioxidant serum." J Cosmet Dermatol. 2024; 23: 145–153. doi:10.1111/jocd.16067
Validation of a midfacial scale and its use in a randomized, evaluator-blinded Study of CPM-HA-V. JDD. Jan 2024
Moradi A, Đakovic R, Odena G. "Aesthetic implantation of calcium hydroxylapatite does not interfere with radiological assessment of bones in the dorsum of the hands." Aesthetic Surgery Journal. 2023; 43(6): 696–703
Moradi A, et al. "Multicenter evaluation of a topical antioxidant serum." J Cosmet Dermatol. 2023
Moradi A, et al. "Guidelines for optimal patient outcomes using calcium hydroxylapatite for jawline contour." Aesthetic Surgery Journal Open Forum. Vol. 5. 2023
Moradi A, et al. "Effectiveness and safety of calcium hydroxylapatite with lidocaine for improving jawline contour." J Drugs Dermatol. 2021; 20(11): 1231–1238
Marcus K, Moradi A, et al. "A randomized trial to assess effectiveness and safety of a hyaluronic acid filler for chin augmentation and correction of chin retrusion." Plast Reconstr Surg. 2022; 150(6): 1240
Chao K, Moradi A, Khalifian S. "DaxibotulinumtoxinA for injection: A review of the current data." Dermatol Rev. 2022; 3(4): 221–230
Jones D, et al. "A randomized, comparator-controlled study of HARC for cheek augmentation and correction of midface contour deficiencies." J Drugs Dermatol. 2021; 20(9): 949–956
Moradi A, et al. "Electromagnetic muscle stimulation: A retrospective study of patient experience." J Cosmet Dermatol. 2022; 21(1): 271–278
Moradi A, Shirazi A. "A retrospective and anatomical study describing the injection of botulinum neurotoxins in the depressor anguli oris." Plast Reconstr Surg. 2022; 149(4): 850–857
Comer JD, Translational Lecture Series, Derm Atlas. "AbobotulinumtoxinA for glabellar lines: A randomized, dose-escalating, double-blind study."
Dayan S, et al. "Subject satisfaction and psychological well-being with escalating abobotulinumtoxinA injection dose for glabellar lines." J Cosmet Dermatol. 2022; 21(6): 2407–2416
Janes LE, et al. "Current use of cosmetic toxins to improve facial aesthetics." Plast Reconstr Surg. 2021; 147(4): 644e–657e
Moradi A, et al. "Validation of photonumeric assessment scales for temple volume deficit, infraorbital hollows, and chin retrusion." Dermatol Surg. 2020; 46(9): 1148–1154
Moradi A, Poehler J, Bell M. "Double-blind trial of TriHex Technology® body treatment with cryolipolysis or RF." J Cosmet Dermatol. 2020; 19(3): 677–681
Jones DH, Swift A, eds. Injectable Fillers: Facial Shaping and Contouring. Wiley. 2019
Poehler J. "Topical body treatment with cryolipolysis: RCT." J Drugs Dermatol. 2019; 18(4): 342–348
Galderma Chin Retrusion Scale Poster: AMWC Conference, Monaco. 2019
The Mandible, Jawline, and Chin. Injectable Fillers: Facial Shaping and Contouring. 2019: 165–173
Moradi A, Shirazi A, David R. "Nonsurgical chin and jawline augmentation with CaHA and HA fillers." Facial Plast Surg. 2019; 35(2): 140–148
Moradi A, et al. "Split-hand study of HA with lidocaine for dorsal hand correction." Plast Reconstr Surg. 2019; 144(4): 586
Goldman MP, et al. "CaHA for dorsal hand volume: 12-month RCT." Dermatol Surg. 2018; 44(1): 75–83
Moradi A, et al. "HA with lidocaine for hand volume: RCT." Plast Reconstr Surg Glob Open. 2018; 6(9 Suppl)
Moradi A, Martin K, Poehler J. "HI-FRM and fractional laser combo for face/neck rejuvenation." Plast Reconstr Surg Glob Open. 2018; 6.85: 160–161
Weiss RA, et al. "HA with lidocaine for midface volume correction." Dermatol Surg. 2016; 42(6): 699–709
Moradi A, Watson J. "Current concepts in filler injection." Facial Plast Surg Clin North Am. 2015; 23(4): 489–494
Sykes JM, et al. "Upper face: clinical anatomy and regional filler techniques." Plast Reconstr Surg. 2015; 136(5): 204S–218S
Lefebvre-Vilardebo M, et al. "Hand: clinical anatomy and filler techniques." Plast Reconstr Surg. 2015; 136(5): 258S–275S
Moradi A, et al. "Split-face pilot of bruising/pain with HA for perioral lines." Aesthet Surg J. 2015; 35(4): 443–455
Moradi A, Palm M. "Extended field radiofrequency safety/efficacy protocol." J Drugs Dermatol. 2015; 14(9): 982–985
"Occipitofrontalis muscle anatomy for botulinum toxin." Aesthet Surg J. 2013; 37(5): 975–983
Moradi A. "SGP-HA for temporal fossa volume loss." J Drugs Dermatol. 2013; 12(4): 470–475
Maas C, et al. "Consensus on abobotulinumtoxinA in practice." Aesthet Surg J. 2012; 32(1 Suppl): 8S–29S
Moradi A, Shirazi A, Perez V. "Temporal fossa augmentation with SGP-HA filler." J Drugs Dermatol. 2011; 10(6): 673–676